Technical Analysis for BME - Blackrock Health Sciences Trust

Grade Last Price % Change Price Change
D 40.23 0.75% 0.30
BME closed up 0.75 percent on Friday, November 1, 2024, on 1.44 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Flat Down Down

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Crossed Above 200 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish 0.75%
Lower Bollinger Band Walk Weakness 0.75%
Multiple of Ten Bearish Other 0.75%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 20 hours ago
Possible Inside Day about 20 hours ago
Rose Above Lower Bollinger Band about 23 hours ago
Rose Above 200 DMA about 23 hours ago
Up 1% about 23 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BlackRock Health Sciences Trust is a close ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets across the globe. The fund invests in the stocks of companies operating in the healthcare sector which includes businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment or services or that provide support services to these companies. It benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Classification

Sector: Financial Services
Industry: Asset Management
Keywords: Exchange Traded Fund ETF Biotechnology Blackrock Health Sciences Technology Products Healthcare Sector Biotechnology Products

Is BME a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 42.1717
52 Week Low 34.6764
Average Volume 28,142
200-Day Moving Average 40.06
50-Day Moving Average 41.41
20-Day Moving Average 41.11
10-Day Moving Average 40.70
Average True Range 0.38
RSI (14) 37.11
ADX 25.08
+DI 9.96
-DI 31.70
Chandelier Exit (Long, 3 ATRs) 40.94
Chandelier Exit (Short, 3 ATRs) 41.08
Upper Bollinger Bands 42.20
Lower Bollinger Band 40.02
Percent B (%b) 0.1
BandWidth 5.31
MACD Line -0.32
MACD Signal Line -0.18
MACD Histogram -0.1384
Fundamentals Value
Market Cap 560.97 Million
Num Shares 13.9 Million
EPS 3.44
Price-to-Earnings (P/E) Ratio 11.69
Price-to-Sales 72.53
Price-to-Book 0.99
PEG Ratio 0.00
Dividend 2.56
Dividend Yield 6.36%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.56
Resistance 3 (R3) 40.56 40.45 40.51
Resistance 2 (R2) 40.45 40.36 40.45 40.49
Resistance 1 (R1) 40.34 40.31 40.39 40.34 40.47
Pivot Point 40.22 40.22 40.25 40.23 40.22
Support 1 (S1) 40.12 40.14 40.17 40.12 39.99
Support 2 (S2) 40.00 40.09 40.00 39.97
Support 3 (S3) 39.89 40.00 39.95
Support 4 (S4) 39.90